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Abstract
Introduction
The aetiology of pain after laparoscopic donor nephrectomy remains unclear. Given the
proximity of the left kidney to the tail of the pancreas, we aimed to assess whether mobilisation
and retrieval of the left kidney might inflame the pancreas, leading to pain and
hyperamylasaemia in the post-operative period.
Patient and methods
In the present study, 16 consecutive live kidney donors were analysed in the same three months
period. Amylase levels were measured on days 1 and 2. For each 24-hour period post-
operatively analgesia consumption was recorded, as well as pain scores at rest on a visual
analogue scale (VAS).
Results
Three out of 16 donors presented hyperamylasemia. A multiple regression analysis found
levobupivacaine dose, propofol dose, transversus abdominis plane block and day 1 amylase did
not significantly predict pain scores. Interestingly, body mass index significantly correlated
with increased pain scores (p = 0.041). Also, increasing CO2 insufflation pressure and use of
local anaesthetic infusion catheters predicted a decreased deep pain score (p = 0.036 and p =
0.037).
Conclusion
There was no correlation of amylase levels and pain scores. Pancreatitis is a rare complication
of nephrectomy and no overt cases were seen in the case of donor nephrectomy.
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Introduction
Laparoscopic living donor nephrectomy (LDN) has eased the burden on the kidney transplant
waiting list by making donation more attractive due to decreased pain, shorter hospital stay,
earlier return to work and smaller scars [1,2]. Although less strenuous and more aesthetically
pleasing than an open procedure, it is still a major operation with post-operative pain,
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physiological stress, morbidity and a 1 in 3500 risk of death [3]. Post-operative complications
include: wound infections, urinary tract infections, ileus, iatrogenic bowel injury, splenic
laceration and impaired renal function [4].
Post-operative pain may be due to port sites, incisions, organ nociception, diaphragmatic
irritation and Foley catheter associated discomfort. Identifying methods to reduce pain is key
as pain leads to increased analgesic requirements (specifically opioids), which has been shown
to significantly increase hospital stay [5]. Opioids also entail side effects of nausea, vomiting,
dizziness, constipation and respiratory depression.
In this study we investigated the possibility that in some cases, post-nephrectomy pain may be
attributed to pancreatitis. This may not be recognised, as the symptoms might be attributed to
another cause. As the kidneys, particularly the left, are in proximity to the pancreas, we
hypothesised that during surgery the pancreas may be agitated, triggering pancreatitis.
We analysed visual analogue scale (VAS) pain scores, calculated Glasgow scores and measured
amylase levels to detect mild pancreatitis contributing to post-operative pain that is currently
unrecognised in this patient population.
We hypothesised that:
There is a positive correlation of VAS pain scores in relation to amylase levels.
There is a larger rise in amylase levels in left nephrectomies in comparison to right
nephrectomies.
An elevated Glasgow Score will have a positive correlation with VAS pain scores.
Materials And Methods
We prospectively collected data from live kidney donors who were scheduled to have a
nephrectomy in our centre over a three-month period. Patient information recorded included:
age, gender, body mass index, previous surgery, past medical history and pre-op bloods (full
blood count (FBC), urea and electrolytes (U+E), bone profile, fasting glucose, liver function tests
(LFTs) and amylase. We documented the emotional relation of the recipient to whom the donor
was donating (sibling, parent, cousin, spouse, etc.).
VAS pain scores were recorded, with a range of 0 to 10. Parameters recorded intraoperatively
were: insufflation pressures, method e.g. laparoscopic, right or left nephrectomy, propofol dose
(mg), use of pre-op transversus abdominis plane (TAP) block and local anaesthetic infiltration
catheter.
Glasgow Score was calculated post-operatively. None of the patients had oxygen saturations
below 96%. Analgesia consumption from intraoperatively until 24 hours post-op was recorded
and patients were asked to estimate their pain scores at rest on a VAS 24 hours after the
operation. This was categorised into incisional pain, shoulder tip pain and deep abdominal
pain. This was repeated daily until discharge, recording analgesic consumption for every 24
hours period since the operation.
All variables were descriptively analysed. Where appropriate, t-test, ANOVA and regression
models were used. Values were considered statistically significant if p < 0.05. Data was analysed
with SPSS, version 23 for Windows (IBM Corp., Armonk, NY).
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Results
There were 16 live kidney donors, all performed laparoscopically. Three live donors were
unrelated and 13 related, five were siblings, three were children and five were parents of the
recipients. The mean donor age was 41.9 (SD 8.6). Six patients were female and 10 were male.
Mean body mass index (BMI) was 27.7 (SD 4.5), range 20-35.4. Table 1 summarises demographic
characteristics for the donors.
Donor ID Age Gender BMI (kg/m2) Relation
1 49 M 26.4 Friend
2 28 M 24 Spouse
3 52 M 25 Spouse
4 45 F 22.4 Spouse
5 38 M 24 Parent
6 58 M 31.9 Child
7 53 F 35.4 Sibling
8 47 F 31.4 Sibling
9 38 M 23 Sibling
10 39 M 28 Parent
11 43 M 33 Parent
12 31 F 20 Child
13 43 F 26 Sibling
14 41 F 30 Parent
15 30 M 32 Parent
16 35 M 30.3 Child
TABLE 1: Donors' demographic characteristics
There were six patients who had abdominal surgery prior to donation. No donor had a history of
pancreatitis. One had a history of gallstones and another recently had a cholecystectomy. One
patient had post-traumatic stress disorder, one had alcohol dependence and three had
depression. There was no significant difference in days 1 and 2 total pain scores between those
with and without depression (p = 0.668 and p = 0.061, respectively). The maximum Glasgow
score was 1 and was either due to patient age or raised white cell count. A one-way ANOVA for
days 1 and 2 total pain scores between groups for relationship of donor to recipient were not
significant, p = 0.606 and p = 0.321, respectively.
The mean dose of levobupivacaine used on day 1 was 369 mg (SD 121 mg). Oral analgesia taken
2020 Bellini et al. Cureus 12(5): e8217. DOI 10.7759/cureus.8217 3 of 8
included: paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), oxycodone, hyoscine
and butylbromide as an adjunct. Day 1 mean deep pain VAS score was 3.6 (SD 3.1), range 0 to
9.5, incisional pain score 3.6 (SD 2.7), range 0 to 8 and shoulder tip pain score 3.1 (SD 3.4),
range 0 to 10. The mean dose of levobupivacaine used on day 2 was 125 mg (SD 111 mg). Day 2
mean deep pain VAS score was 2.1 (SD 2.2), range 0 to 6, incisional pain score 1.5 (SD 0.9) range
0 to 3 and shoulder tip pain score 0.9 (SD 1.4) range 0 to 5.
Three patients had a modestly elevated amylase level at 126, 155 and 159 U/L (normal range 28-
100 U/L) on Day 1 post-operatively. Their corresponding pain scores can be seen in Table 2.
 Amylase level Deep pain Incisional pain Shoulder tip pain
Donor no. 2 126 U/L 4 8 1
Donor no. 10 155 U/L 8 6 0
Donor no. 15 159 U/L 0 0.5 2
TABLE 2: Pain scores for the donors with day 1 hyperamylasaemia
A multiple regression was run to predict VAS day 1 deep pain scores from: day 1
levobupivacaine dose, propofol dose, BMI, transversus abdominis plane (TAP) block, local
anaesthetic wound catheter, day 1 amylase and CO2 insufflation pressure. None of these
variables significantly predicted VAS day 1 deep pain score p = 0.463, R2 = 0.518. Table 3 details
values for each variable.
 B Significance
BMI -0.311 0.219
CO2 insufflation pressure -1.020 0.340
Propofol dose -0.041 0.139
Day 1 amylase level 0.030 0.359
TAP block -1.483 0.315
Local anaesthetic wound catheter use -1.350 0.789
Day 1 levobupivacaine dose 0.011 0.485
TABLE 3: Multiple regression analysis for day 1 deep VAS pain scores
VAS: Visual analogue scale; TAP: Transversus abdominis plane.
A multiple regression was run to predict VAS day 2 deep pain scores from: BMI, local
anaesthetic wound catheter use, day 2 amylase and CO2 insufflation pressure. These variables
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significantly predicted VAS day 2 deep pain score, p = 0.046, R2 = 0.710. Table 4 details values
for each variable.
 B Significance
BMI 0.689 0.011
CO2 insufflation pressure -1.533 0.014
Day 2 amylase level -0.031 0.705
Local anaesthetic wound catheter use -9.782 0.007
TABLE 4: Multiple regression analysis for day 2 deep VAS pain scores
VAS: Visual analogue scale
There is no positive correlation of VAS pain scores in relation to amylase levels on days 1 or 2.
There is positive correlation of VAS pain scores in relation to insufflation pressures, for every 1
mmHg increase in CO2 pressure there is a decrease in day 2 VAS deep pain scores by -1.533.
There was no significant correlation when analysing shoulder tip pain on days 1 and 2 (p =
0.247 and p = 0.326). The median CO2 insufflation pressure was 12 mmHg (range 10-15
mmHg). Increasing BMI predicted an increased day 2 pain score, p = 0.011. All patients had
local anaesthetic wound catheter use, however it did not function in one patient. Local
anaesthetic wound catheter use predicted a decreased deep pain score (p = 0.007). Eight
patients had a TAP block; two were bilateral and six were unilateral on the side of the
nephrectomy.
One patient had a right nephrectomy and 15 had left nephrectomies. An independent t-test
found no significant difference in day 1 and day 2 amylase levels between right versus left
nephrectomy, p = 0.722 and p = 0.904, respectively.
Discussion
The primary aim of the present study was to investigate whether pain scores positively
correlate with amylase levels. There were no overt cases of pancreatitis, but we detected
hyperamylasaemia in three patients post-operatively. More in details, in Table 1, the donor
with the highest amylase level had low pain scores in each category whilst the others had
moderate to high scores. This was reinforced by multiple regression analysis, as amylase levels
did not predict deep pain scores (p = 0.359 day 1 and p = 0.705 day 2). There was no significant
difference in day 1 or day 2 amylase levels between right versus left nephrectomy, p = 0.722 and
p = 0.904, respectively.
Day 1 pain scores for deep, incisional and shoulder tip were on average 3.6, 3.6 and 3.1,
respectively. Day 2 pain scores for deep, incisional and shoulder tip were on average 2.1, 1.5 and
0.9, respectively. This reflects good pain control in the donors overall, however the range of
scores on day 1 still reaches 9.5, 8 and 10, respectively. Many patients described feeling bloated,
which was not eased by several modes of analgesia and only slightly dulled by buscopan. For
every unit increase in BMI the regression analysis predicts an increased day 2 VAS pain score (p
= 0.011), possibly due to increasing technical difficulty of the operation, requiring greater
mobilisation of the viscera.
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Multiple regression analysis predicted that for every 1 mmHg increase in CO2 pressure there is
a decrease in day 2 VAS deep pain scores (p = 0.014). This was not significant on day 1 or when
analysing shoulder tip pain on days 1 and 2 (p = 0.247 and p = 0.326). This was unexpected, as it
has been previously reported that lower pneumoperitoneum pressures reduce post-operative
pain. Warle et al. compared 7 mmHg vs 14 mmHg and found lower pressure resulted in a lower
overall pain score, referred pain score and deep pain score [6]. There was no difference in
complication rate, but it resulted in longer skin-to-skin time and potentially a poor view of the
operative field due to low pressure. Our findings should be interpreted with caution because of
low patient numbers. It may be that a higher-pressure pneumoperitoneum allows ideal
visualisation of the operative field and possibly a more efficient nephrectomy with less
movement of neighbouring viscera.
Our centre routinely conducts a TAP block prior to nephrectomy [7]. We did not analyse this
further due to the time when the first pain scores were collected being 24 hours after surgery by
which time the TAP block would have worn off.
A study by Azawi et al. compared TAP block versus local ropivacaine injection and found in
reference to the visual analogue scale (VAS) that TAP block did not reduce pain or opioid
consumption (VAS 3.05 vs 1.44 P = 0.001) [8]. They hypothesised that this difference in VAS
scores was possibly due to the TAP block wearing off by the time the patient was awake. In
comparison, Parikh et al. found reduced tramadol consumption and reduced VAS score up to 12
hours post op and Hosgood et al. found reduced early morphine consumption [9]. Before closure
of incisions, local anaesthetic wound catheters are inserted, and injected with chirocaine or
levobupivacaine. When back on the ward these are attached to a bag of 0.125%
levobupivacaine, which commonly infuses at a rate of 10 ml/hour for 24-48 hours after
nephrectomy. Use of these catheters predicted a decreased deep pain score (p = 0.007) on day 2
which indicates their effectiveness and allows continuous analgesia to the TAP.
A literature review discovered a total of 16 cases of pancreatitis post-nephrectomy for urologic
indication, though none for transplant donor nephrectomy. More details are shown in Table 5
[1, 4, 8-12].
Authors Number of pancreatitis events Nephrectomy procedure
Al-Ali et al. [13] 1 Open
Dunn et al. [10] 1 Open
Hawasli et al. [11] 1 Laparoscopic
Jacobs et al. [5] 4 Laparoscopic
Kortram et al. [1] 3 Minimally invasive
Pietrow et al. [4] 2 Hand assisted
Varkarakis et al. [12] 4 Adrenalectomy and laparoscopic nephrectomy
TABLE 5: Number of cases of pancreatitis documented as a post-operative event
during nephrectomy
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We felt that given the longer length of vessels needed for donor nephrectomy versus urologic
nephrectomy, there might be more pancreatic mobilisation and pancreatitis in the donor
operation. Incidence of pancreatitis in urologic series varied from 0.3% to 3.3%. Varkarakis et
al. documented four pancreatic injuries during urological surgery: two during adrenalectomy
and two as a result of nephrectomy [12]. Two of these were associated with epigastric pain and
hyperamylasaemia and the overall incidence was 0.44%. Al-Ali et al. presented a case of acute
pancreatitis after a right radical transperitoneal open nephrectomy [13]. The patient developed
abdominal and back pain, jaundice and fever and was admitted to ITU for 15 days.
Other case reports including Devlin et al. and Gottschling et al. have presented cases of
propofol-induced pancreatitis, unrelated to surgery [14,15]. In Gottschling’s case report, a
young girl was described who was given propofol for an MRI scan and then developed
pancreatitis within hours. A large majority of patients having a nephrectomy are anaesthetised
with propofol, so differentiating between propofol and abdominal surgery, as the cause of
pancreatitis, may be challenging.
Wang et al. compared VAS in living donors and patients undergoing similar surgical procedures
for removal of renal cell carcinoma [16]. They found that in donors, time to tramadol request
was quicker, amount of tramadol consumed was higher and VAS scores were higher in the first 8
hours. There was no clear reason for this, but they proposed it, may be due to difference in the
perception of pain, as the donor is only benefiting someone else whereas cancer patients
benefit directly. They speculated that the donor may experience more pain as it is contributed
to psychologically. They also felt that doctors and nurses might pay more attention to donors,
resulting in earlier administration and more analgesia. We investigated whether there was a
significant difference between the type of relation of the donor to the recipient and pain scores,
hypothesising that those who were more closely related to the recipient might have lower pain
scores than those who were more distantly related, however, we found no significant difference.
Conclusions
In conclusion, in laparoscopic LDN post-operative pain remains of unknown aetiology. We
investigated the possibility that post-nephrectomy pain could be attributed to
hyperamylasemia as the kidneys, particularly the left, are in proximity to the pancreas, but this
is not the case as post-operative pain scores are not correlated with amylase levels, while
increasing BMI and reduced insufflation pressure correlated with increased deep pain scores.
Local anaesthetic wound catheter use significantly reduced deep pain scores.
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